Operating Income (Loss) in USD of BioCorRx Inc. from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BioCorRx Inc. quarterly/annual Operating Income (Loss) history and change rate from 2014 to Q3 2025.
  • BioCorRx Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$1.95M, a 17.2% decline year-over-year.
  • BioCorRx Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$5.42M, a 12.5% decline year-over-year.
  • BioCorRx Inc. annual Operating Income (Loss) for 2024 was -$5.12M, a 35.2% decline from 2023.
  • BioCorRx Inc. annual Operating Income (Loss) for 2023 was -$3.79M, a 19.4% increase from 2022.
  • BioCorRx Inc. annual Operating Income (Loss) for 2022 was -$4.7M, a 14.7% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BioCorRx Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$5.42M -$1.95M -$286K -17.2% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$5.14M -$1.41M -$44.6K -3.26% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$5.09M -$938K +$30.7K +3.17% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$5.12M -$1.12M -$302K -36.7% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 -$4.82M -$1.66M -$698K -72.6% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$4.12M -$1.37M -$422K -44.6% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$3.7M -$969K +$87.6K +8.3% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$3.79M -$823K +$363K +30.6% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 -$4.15M -$962K +$67.3K +6.54% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$4.22M -$947K +$411K +30.3% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$4.63M -$1.06M +$68.4K +6.08% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$4.7M -$1.19M +$147K +11% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 -$4.84M -$1.03M +$606K +37% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$5.45M -$1.36M -$395K -41% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$5.06M -$1.12M +$455K +28.8% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$5.51M -$1.33M +$434K +24.6% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$5.94M -$1.63M +$418K +20.4% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$6.36M -$963K +$1.19M +55.3% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$7.55M -$1.58M -$61.6K -4.06% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$7.49M -$1.77M -$172K -10.8% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 -$7.32M -$2.05M -$1.17M -132% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$6.15M -$2.15M -$554K -34.6% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 -$5.6M -$1.52M -$37.3K -2.52% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$5.56M -$1.6M +$349K +18% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 -$5.91M -$886K +$515K +36.8% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 -$6.43M -$1.6M -$858K -116% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$5.57M -$1.48M -$941K -175% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 -$4.63M -$1.94M -$916K -89.1% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 -$3.71M -$1.4M -$737K -111% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$2.97M -$741K +$45.2K +5.74% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$3.02M -$539K -$127K -30.7% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 -$2.89M -$1.03M -$111K -12.1% 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2019
Q3 2017 -$2.78M -$664K -$146K -28.3% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$2.63M -$787K -$374K -90.8% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$2.26M -$412K -$77.7K -23.2% 01 Jan 2017 31 Mar 2017 10-Q 18 May 2018
Q4 2016 -$2.18M -$918K -$222K -31.8% 01 Oct 2016 31 Dec 2016 10-K 05 Apr 2018
Q3 2016 -$1.96M -$517K -$11K -2.18% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$1.95M -$412K +$3.5M +89.4% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 -$5.44M -$335K -$327K -4264% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$5.12M -$696K 01 Oct 2015 31 Dec 2015 10-K 13 Apr 2017
Q3 2015 -$506K 01 Jul 2015 30 Sep 2015 10-Q 17 Nov 2016
Q2 2015 -$3.91M 01 Apr 2015 30 Jun 2015 10-Q 17 Aug 2016
Q1 2015 -$7.67K 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016

BioCorRx Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$5.12M -$1.33M -35.2% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 -$3.79M +$910K +19.4% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 -$4.7M +$812K +14.7% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 -$5.51M +$1.98M +26.5% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$7.49M -$1.93M -34.7% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$5.56M -$935K -20.2% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 -$4.63M -$1.74M -60% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 -$2.89M -$709K -32.5% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019
2016 -$2.18M +$2.94M +57.4% 01 Jan 2016 31 Dec 2016 10-K 05 Apr 2018
2015 -$5.12M -$2.07M -67.7% 01 Jan 2015 31 Dec 2015 10-K 13 Apr 2017
2014 -$3.05M 01 Jan 2014 31 Dec 2014 10-K 14 Apr 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.